CAN INCREASED FUNDING IN THE NIH AND DOD PLAY A ROLE IN THE NATIONAL ECONOMIC STIMULUS PACKAGE AND HELP FIGHT PROSTATE CANCER?

Many members of Congress see the potential of an increased investment in the NIH as part of the solution to our ailing economy. We prostate cancer survivors can glean additional benefits from an increase to NIH funding, in our fight against this terrible disease. The belief that making an increased economic investment in research through [...]

FDA Approves New Drug to Alleviate Moderate to Severe Pain

The U.S. Food and Drug Administration (FDA) has approved a new drug which provides relief of moderate to severe acute pain. This is great news for us, because, advanced prostate cancer often brings pain from mets and breaking bones. This newly approved drug, tapentadol hydrochloride, is delivered as an immediate-release oral tablet. It is a [...]

So, What Happened In The Clinical Trial?

There is a lot of pressure on cancer survivors to participate in clinical trials. Without the brave individuals willing to participate in the trials research would grind to a halt along with new, improved treatments for all cancers. Even though an estimated 2.3 million people in the United States take part in clinical trials every [...]

Go to Top